Dorelia Rivera talks about health disparities, a career in advocacy and saving her daughter’s life

 

 

 

About this episode:

 

Our guest this episode, patient advocate Dorelia Rivera, improves access to healthcare services and clinical trials for the underrepresented, including her own Hispanic community. Her advocacy ranges from community volunteer work, to jobs for a state health and human services department, a payor, and a rare disease drug company. She advocates on Capitol Hill and served on the National Institutes of Health Advisory Council on Diversity 

She’s also a mother of a child with a rare disease. Rivera’s daughter has an ultra-rare condition, NOMID--neonatal onset multisystem inflammatory disease. When she was first diagnosed, the doctor said she wouldn’t live to be 10 years old. Today, she is thriving teenager, thanks to an NIH clinical trial and her mother’s persistence. 

Rivera talks about her daughter and her advocacy for underserved communities. Like those with rare diseases, racial and ethnic minorities are too often overlooked.

“Health disparities are real,” she says. The COVID-19 pandemic and the current protests are driving that home, she adds. “It’s painfully, painfully, painfully evident.” Changes need to be made concurrently across several areas, including insurance coverage, access to care, access to clinical trials, and a greater focus on the social determinants of health. “Healthcare should be a right, not a privilege.”

In terms of clinical trials, sponsors need to understand the barriers many patients--especially those in minority communities--face. Someone who needs to leave work to participate in a trial may not have a job when they return. Too often, trial sponsors aren’t flexible in addressing the obstacles potential participants face. If sponsors want to improve diversity, they need to level the playing field. “They have to meet the families where they are.” 

About the Author

Steve Smith | President, Patient Advocacy, WCG

Steve Smith is a seasoned patient advocate with an extensive career in software, consulting, process transformation, health care systems and patient-focused drug development. He joined WCG as President Patient Advocacy in 2019 inspired by the incredible value to patients embedded in the wide range of WCG solutions that reduce the time and cost of clinical trials.

Visit Website More Content by Steve Smith | President, Patient Advocacy, WCG
Previous Post
Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About Health
Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About Health

Next Post
Christopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in Philadelphia
Christopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in Philadelphia